Bio Essence (BIOE) Free Cash Flow (2020 - 2026)
Bio Essence (BIOE) recorded quarterly Free Cash Flow of -$411970.0 in Q1 2026, down 133.2% quarter-over-quarter from $1.2 million in Q4 2025, and down 1480.31% on a YoY basis from $29846.3 in Q1 2025.
Bio Essence (BIOE) Free Cash Flow (2020 - 2026) Analysis & Trends
Bio Essence's Free Cash Flow history runs 7 years deep, the most recent figure standing at -$411970.0 for Q1 2026.
- In Q1 2026, Free Cash Flow fell 1480.31% year-over-year to -$411970.0; the TTM figure through Mar 2026 stood at $1.2 million (up 50.74% YoY), while the FY2025 annual figure was $1.6 million, up 145.34% from the prior year.
- Free Cash Flow was -$411970.0 for Q1 2026 at Bio Essence, down from $1.2 million in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of $1.2 million in Q4 2025 to a low of -$696848.0 in Q3 2023.
- Historically, Free Cash Flow has averaged $6511.6 across 5 years, with a median of -$79432.0 in 2022.
- The sharpest annual moves came in 2025 and 2026: Free Cash Flow jumped 998.65% in 2025, then tumbled 1480.31% in 2026.
- A 5-year view of Free Cash Flow shows it stood at -$79432.0 in 2022, then tumbled by 101.28% to -$159880.0 in 2023, then jumped by 374.59% to $439018.0 in 2024, then surged by 182.69% to $1.2 million in 2025, then sank by 133.2% to -$411970.0 in 2026.
- The last three Free Cash Flow figures came in at -$411970.0 (Q1 2026), $1.2 million (Q4 2025), and $186973.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -208.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 291.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 362.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 136.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | -38.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -169.83 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 80.53 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 123.09 Mn |
| 10 | Bio Essence | - | - | 319,353.00 | -411,970.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -411,970.00 |
| Mar 31, 2026 | -411,970.00 |
| Dec 31, 2025 | 1.24 Mn |
| Dec 31, 2025 | 1.24 Mn |
| Sep 30, 2025 | 186,973.00 |
| Sep 30, 2025 | 186,973.00 |
| Jun 30, 2025 | 167,797.00 |
| Jun 30, 2025 | 167,797.00 |
| Mar 31, 2025 | -26,069.00 |
| Mar 31, 2025 | -26,069.00 |
| Dec 31, 2024 | 439,018.00 |
| Dec 31, 2024 | 439,018.00 |
| Sep 30, 2024 | 357,139.00 |
| Sep 30, 2024 | 357,139.00 |
| Jun 30, 2024 | 15,273.00 |
| Jun 30, 2024 | 15,273.00 |
| Mar 31, 2024 | -171,613.00 |
| Mar 31, 2024 | -171,613.00 |
| Dec 31, 2023 | -159,880.00 |
| Dec 31, 2023 | -159,880.00 |